New York, NY -- (SBWIRE) -- 11/02/2013 -- StockMarketIntel.com issues a special report on the following stocks: Thoratec Corporation (NASDAQ:THOR), VIVUS, Inc. (NASDAQ:VVUS), Cerus Corporation (NASDAQ:CERS), Star Scientific, Inc. (NASDAQ:STSI)
Thoratec Corporation (NASDAQ:THOR) recently declined -3.01%, while trading on 1.13M shares, at the price of $41.91. The stock changed hands in a range of $41.73 to $43.03 up till now, bringing its market capitalization at about $2.41 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $29.91 and was moved to the maximum level of $43.58. Thoratec Corporation is engaged in mechanical circulatory support with a product portfolio to treat the range of clinical needs for advanced heart failure (HF) patients. The Company develops, manufactures and markets medical devices used for circulatory support.
Has THOR Found The Bottom and Ready To Move Up? Find Out Here
VIVUS, Inc. (NASDAQ:VVUS) recently added 1.49% while trading on 1.10M shares, at the price of $9.53. The stock changed hands in a range of $9.28 to $9.57 up till now. If we look at its trading history of the past 52 weeks, the share price suffered a low of $9.11 and was moved to the maximum level of $15.62. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health.
For How Long VVUS Gloss will Attract Investors? Find out via this report
Cerus Corporation (NASDAQ:CERS) recently added 1.58% and was moving within a range of $6.22 -$6.44. Its current trading price is $6.41. The share price hit its 52-week low of $2.68 and $7.13 was the best price. The stock completed the day with a total volume of 1.10M shares, versus an average volume of 627,318.00 shares. Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on the Company's technology for controlling biological replication, is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion.
Will CERS Continue To Move Higher? Find Out Here
Star Scientific, Inc. (NASDAQ:STSI) added 3.91% in its current trading activity, bringing its market capitalization around $314.47 million. The total number of shares that changed hands during the current session up till now was 1.12 million shares, as compared to average trading volume of 1.07 million shares. The share price after opening at $1.80 made a high of $1.88 and hovered above $1.76, while its recent trading price was $1.86. Star Scientific, Inc. (Star Scientific) is engaged in the manufacturing and production of dietary supplements. The Company’s operating subsidiaries manufacture, distribute and sell consumer products and dietary supplements.
Why Should Investors Buy STSI After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)